Company Search:
Advanced Search
Sponsored Links
D.Western Therapeutics Institute Incorporation Company Snapshot
D.Western Therapeutics Institute Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares D.Western Therapeutics Institute Incorporation with three other companies in this sector in Japan: Canbas Co Ltd (2015 sales of 60.96 million Japanese Yen [US$533,992.08 ] of which 100% was Develop Of Anticancer), Medrx Co Ltd (37.61 million Japanese Yen [US$329,481.12 ] ), and Healios Kk (98.17 million Japanese Yen [US$859,942.92 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
D.Western Therapeutics Institute Incorporation
  Stock Performance Chart for D.Western Therapeutics Institute Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 413.00
(Figures in Japanese Yen)
1 Week -4.2%   13 Weeks 1.5%  
4 Weeks -4.6%   52 Weeks -10.8%  
D.Western Therapeutics Institute Incorporation Key Data:
  Ticker: 4576 Country: Japan
  Exchanges: TYO JSQ Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 61,818,000
(Year Ending Jan 2016).
Employees: 15
  Currency: Japanese Yen Market Cap: 10,225,219,200
  Fiscal Yr Ends: December Shares Outstanding: 24,758,400
  Share Type: Common Closely Held Shares: 8,453,900
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.